Please Wait.....
Report
Alzheimer's Drugs - A Global Market Overview
Market Report I 2024-09-27 I 253 Pages I Industry Experts
Alzheimer's Drugs Market Trends and Outlook
Alzheimer's disease is a degenerative neurological condition that progresses over time and is the primary cause of dementia, typically impacting individuals aged 65 and older. It is defined by memory loss, cognitive decline, and the formation of plaques and tangles in the brain that interrupt neuron communication. Alzheimer's disease advances in phases, ranging from mild cognitive impairment to severe dementia, though the pace varies for each person. Although there is no cure, drugs such as cholinesterase inhibitors and NMDA receptor antagonists can help delay the progression of symptoms. Combination medications, like the combination of donepezil and memantine, provide a more comprehensive treatment option for moderate to severe stages. Novel treatments like monoclonal antibodies and anti-amyloid drugs efficiently treat the disease. However, the current medicines only aim to control symptoms of Alzheimer's disease instead of reversing it.
The global market for Alzheimer's Drugs will likely maintain a robust CAGR of 9.9% during the 2024-2030 analysis period and reach a projected US$9.2 billion by 2030 from an estimated US$5.2 billion in 2024.
The rising prevalence of Alzheimer's disease, driven mainly by the aging population, is leading to the expansion of the Alzheimer's drugs market. With the increase in life expectancy, especially in developed countries, there is a growing number of people at risk for Alzheimer's disease, leading to a larger group of potential patients. Innovations in drug development, such as medications aimed at the root cause of illnesses, combined with increased awareness and early diagnoses, further drive this market growth. Additionally, governments and healthcare organizations are boosting their financial support for Alzheimer's research, accelerating the development of new drugs, and expediting regulatory approvals. However, several factors hinder market growth, including the high cost and complexity of drug development, frequent clinical trial failures, patent expirations, limited awareness of Alzheimer's in underdeveloped countries, and the high cost of treatments, which restrict accessibility and market potential.
Alzheimer's Drugs Regional Market Analysis
North America leads the Alzheimer's drugs market with an estimated share of 38.9% in 2024, driven by a high prevalence of the disease, recent drug approvals, and advanced healthcare systems. The region benefits from major pharmaceutical companies conducting research and clinical trials alongside an aging population. Conversely, the Asia Pacific region is projected to be the fastest-growing market, with a CAGR of 11.5% during the analysis period 2024-2030. This growth is fueled by the rising prevalence of Alzheimer's, increased awareness, and a focus on unmet medical needs, particularly in countries like China and India. The region's less stringent regulations make it an attractive location for clinical trials and drug development.
Alzheimer's Drugs Market Analysis by Drug Class
Cholinesterase inhibitors dominate the Alzheimer's drugs market, holding an estimated 42.3% share in 2024, driven by their effectiveness in treating mild-to-moderate Alzheimer's through increased acetylcholine levels. Their oral administration and proven efficacy solidify their role as primary treatment. Conversely, the others segment, which includes monoclonal antibodies, anti-amyloid beta drugs, and pipeline drugs, is expected to register the fastest CAGR of 11.9% during the analysis period 2024-2030, fueled by rising regulatory approvals and the launch of disease-modifying therapies targeting Alzheimer's pathology.
Alzheimer's Drugs Market Analysis by Route of Administration
Oral drugs lead the market with an estimated share of 57% in 2024 due to their ease of administration and non-invasive nature, which enhances patient compliance. Oral medications, such as cholinesterase inhibitors, can be self-administered, providing convenience for patients, especially elderly individuals with multiple comorbidities. The injectable segment is projected to record the fastest growth, with a CAGR of 11.7% during the forecast period from 2024 to 2030, driven by monoclonal antibodies like Aducanumab and Leqembi, which offer potential disease-modifying effects for advanced Alzheimer's stages.
Alzheimer's Drugs Market Analysis by Distribution Channel
The hospital pharmacy segment dominates the market with an estimated 47.7% share in 2024, driven by increasing procurement of prescription drugs and its role in integrated care models. Hospital pharmacies coordinate multidisciplinary approaches that include pharmaceutical interventions, counseling, and community support, ensuring comprehensive care for Alzheimer's patients. Meanwhile, the online pharmacy segment is anticipated to grow significantly, with a CAGR of 12.7% during the analysis period 2024-2030. This growth is fueled by the rising number of Alzheimer's patients and the convenience of online purchasing, which is particularly beneficial for elderly people, and disabled individuals, supported by increased internet usage and digital service adoption.
Alzheimer's Drugs Market Report Scope
This global report on Alzheimer's Drugs analyzes the market based on drug class, route of administration and distribution channels. In addition to providing profiles of major companies operating in this space, the latest corporate and industrial developments have been covered to offer a clear panorama of how and where the market is progressing.
Key Metrics
Historical Period: 2021-2023
Base Year: 2023
Forecast Period: 2024-2030
Units: Value market in US$
Companies Mentioned: 10+
Alzheimer's Drugs Market by Geographic Region
- North America (The United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, and Rest of Europe)
- Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific)
- South America (Brazil, Argentina, and Rest of South America)
- Rest of World
Alzheimer's Drugs Market by Drug Class
- Cholinesterase Inhibitors
- NMDA Receptor Antagonists
- Combination Drugs
- Others (Including Monoclonal Antibodies, Anti-amyloid Beta, Nutritional supplements, and Pipeline Drugs)
Alzheimer's Drugs Market by Route of Administration
- Oral
- Injectable
- Transdermal Patch
Alzheimer's Drugs Market by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
PART A: GLOBAL MARKET PERSPECTIVE
1. INTRODUCTION
- Product Outline
- Alzheimer's Drugs Defined
- Alzheimer's Drug Classes
o Cholinesterase Inhibitors
o NMDA Receptor Antagonists
o Combination Drugs
o Others (Including Monoclonal Antibodies, Anti-amyloid Beta, Nutritional supplements, and Pipeline Drugs)
- Alzheimer's Drug Route of Administration
o Oral
o Injectable
o Transdermal Patch
- Alzheimer's Drug Distribution Channels
o Hospital Pharmacy
o Retail Pharmacy
o Online Pharmacy
2. Key Market Trends
3. Key Global Players
- AbbVie Inc.
- AstraZeneca PLC
- Biogen Inc.
- Daiichi Sankyo Company, Limited
- Eisai Co., Ltd.
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- H. Lundbeck A/S
- Johnson & Johnson Innovative Medicine
- Lupin Limited
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
4. Key Business & Product Trends
5. Global Market Overview
- Global Alzheimer's Drugs Market Overview by Drug Class
o Alzheimer's Drug Class Market Overview by Global Region
- Cholinesterase Inhibitors
- NMDA Receptor Antagonists
- Combination Drugs
- Others
- Global Alzheimer's Drugs Market Overview by Route of Administration
o Alzheimer's Drugs Route of Administration Market Overview by Global Region
- Oral
- Injectable
- Transdermal Patch
- Global Alzheimer's Drugs Market Overview by Distribution Channel
o Alzheimer's Drugs Distribution Channel Market Overview by Global Region
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
PART B: REGIONAL MARKET PERSPECTIVE
Global Alzheimer's Drugs Market Overview by Geographic Region
REGIONAL MARKET OVERVIEW
6. North America
- North American Alzheimer's Drugs Market Overview by Geographic Region
- North American Alzheimer's Drugs Market Overview by Drug Class
- North American Alzheimer's Drugs Market Overview by Route of Administration
- North American Alzheimer's Drugs Market Overview by Distribution Channel
- Country-wise Analysis of North American Alzheimer's Drugs Market
o The United States
- United States Alzheimer's Drugs Market Overview by Drug Class
- United States Alzheimer's Drugs Market Overview by Route of Administration
- United States Alzheimer's Drugs Market Overview by Distribution Channel
o Canada
- Canadian Alzheimer's Drugs Market Overview by Drug Class
- Canadian Alzheimer's Drugs Market Overview by Route of Administration
- Canadian Alzheimer's Drugs Market Overview by Distribution Channel
o Mexico
- Mexican Alzheimer's Drugs Market Overview by Drug Class
- Mexican Alzheimer's Drugs Market Overview by Route of Administration
- Mexican Alzheimer's Drugs Market Overview by Distribution Channel
7. Europe
- European Alzheimer's Drugs Market Overview by Geographic Region
- European Alzheimer's Drugs Market Overview by Drug Class
- European Alzheimer's Drugs Market Overview by Route of Administration
- European Alzheimer's Drugs Market Overview by Distribution Channel
- Country-wise Analysis of European Alzheimer's Drugs Market
o Germany
- German Alzheimer's Drugs Market Overview by Drug Class
- German Alzheimer's Drugs Market Overview by Route of Administration
- German Alzheimer's Drugs Market Overview by Distribution Channel
o France
- French Alzheimer's Drugs Market Overview by Drug Class
- French Alzheimer's Drugs Market Overview by Route of Administration
- French Alzheimer's Drugs Market Overview by Distribution Channel
o The United Kingdom
- United Kingdom Alzheimer's Drugs Market Overview by Drug Class
- United Kingdom Alzheimer's Drugs Market Overview by Route of Administration
- United Kingdom Alzheimer's Drugs Market Overview by Distribution Channel
o Italy
- Italian Alzheimer's Drugs Market Overview by Drug Class
- Italian Alzheimer's Drugs Market Overview by Route of Administration
- Italian Alzheimer's Drugs Market Overview by Distribution Channel
o Spain
- Spanish Alzheimer's Drugs Market Overview by Drug Class
- Spanish Alzheimer's Drugs Market Overview by Route of Administration
- Spanish Alzheimer's Drugs Market Overview by Distribution Channel
o Rest of Europe
- Rest of Europe Alzheimer's Drugs Market Overview by Drug Class
- Rest of Europe Alzheimer's Drugs Market Overview by Route of Administration
- Rest of Europe Alzheimer's Drugs Market Overview by Distribution Channel
8. Asia-Pacific
- Asia-Pacific Alzheimer's Drugs Market Overview by Geographic Region
- Asia-Pacific Alzheimer's Drugs Market Overview by Drug Class
- Asia-Pacific Alzheimer's Drugs Market Overview by Route of Administration
- Asia-Pacific Alzheimer's Drugs Market Overview by Distribution Channel
- Country-wise Analysis of Asia-Pacific Alzheimer's Drugs Market
o Japan
- Japanese Alzheimer's Drugs Market Overview by Drug Class
- Japanese Alzheimer's Drugs Market Overview by Route of Administration
- Japanese Alzheimer's Drugs Market Overview by Distribution Channel
o China
- Chinese Alzheimer's Drugs Market Overview by Drug Class
- Chinese Alzheimer's Drugs Market Overview by Route of Administration
- Chinese Alzheimer's Drugs Market Overview by Distribution Channel
o India
- Indian Alzheimer's Drugs Market Overview by Drug Class
- Indian Alzheimer's Drugs Market Overview by Route of Administration
- Indian Alzheimer's Drugs Market Overview by Distribution Channel
o South Korea
- South Korean Alzheimer's Drugs Market Overview by Drug Class
- South Korean Alzheimer's Drugs Market Overview by Route of Administration
- South Korean Alzheimer's Drugs Market Overview by Distribution Channel
o Rest of Asia-Pacific
- Rest of Asia-Pacific Alzheimer's Drugs Market Overview by Drug Class
- Rest of Asia-Pacific Alzheimer's Drugs Market Overview by Route of Administration
- Rest of Asia-Pacific Alzheimer's Drugs Market Overview by Distribution Channel
9. South America
- South American Alzheimer's Drugs Market Overview by Geographic Region
- South American Alzheimer's Drugs Market Overview by Drug Class
- South American Alzheimer's Drugs Market Overview by Route of Administration
- South American Alzheimer's Drugs Market Overview by Distribution Channel
- Country-wise Analysis of Asia-Pacific Alzheimer's Drugs Market
o Brazil
- Brazilian Alzheimer's Drugs Market Overview by Drug Class
- Brazilian Alzheimer's Drugs Market Overview by Route of Administration
- Brazilian Alzheimer's Drugs Market Overview by Distribution Channel
o Argentina
- Argentine Alzheimer's Drugs Market Overview by Drug Class
- Argentine Alzheimer's Drugs Market Overview by Route of Administration
- Argentine Alzheimer's Drugs Market Overview by Distribution Channel
o Rest of South America
- Rest of South American Alzheimer's Drugs Market Overview by Drug Class
- Rest of South American Alzheimer's Drugs Market Overview by Route of Administration
- Rest of South American Alzheimer's Drugs Market Overview by Distribution Channel
10. Rest of World
- Rest of World Alzheimer's Drugs Market Overview by Drug Class
- Rest of World Alzheimer's Drugs Market Overview by Route of Administration
- Rest of World Alzheimer's Drugs Market Overview by Distribution Channel
PART C: GUIDE TO THE INDUSTRY
PART D: ANNEXURE
1. RESEARCH METHODOLOGY
2. FEEDBACK
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security